BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 16246481)

  • 41. [Endometrial cancer in HNPCC syndrome].
    Lécuru F; Ansquer Y; Bats AS; Olschwang S; Laurent-Puig P; Eisinger F
    J Gynecol Obstet Biol Reprod (Paris); 2008 Oct; 37(6):547-53. PubMed ID: 18650032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Conservative treatment of endometrial cancer and atypical hyperplasia].
    Yazbeck C; Dhainaut C; Thoury A; Driguez P; Madelenat P
    Gynecol Obstet Fertil; 2004 May; 32(5):433-41. PubMed ID: 15177216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The risk of premalignant and malignant pathology in endometrial polyps.
    Bakour SH; Khan KS; Gupta JK
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):317-20. PubMed ID: 10746849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Surgical treatment of precancer and cancer of endometrium].
    Ivanov S; Khadzhiolov N; Batashki I
    Akush Ginekol (Sofiia); 2007; 46(6):12-4. PubMed ID: 17974165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of Pipelle Mark II sampling in endometrial disease diagnosis.
    Polena V; Mergui JL; Zerat L; Sananes S
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):233-7. PubMed ID: 17029754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The accuracy of frozen pathology at time of hysterectomy in patients with complex atypical hyperplasia on preoperative biopsy.
    Indermaur MD; Shoup B; Tebes S; Lancaster JM
    Am J Obstet Gynecol; 2007 May; 196(5):e40-2. PubMed ID: 17466676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
    Ivanov S
    Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.
    Kresowik J; Ryan GL; Van Voorhis BJ
    Obstet Gynecol; 2008 Feb; 111(2 Pt 2):547-9. PubMed ID: 18239018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Methods and efficacy of medical and surgical treatment of non functional menorrhagia].
    Brun JL; André G; Descat E; Creux H; Vigier J; Dallay D
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S368-83. PubMed ID: 19268216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of abnormal uterine bleeding and the pathology of endometrial hyperplasia.
    Espindola D; Kennedy KA; Fischer EG
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):717-37, ix. PubMed ID: 18061866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Thin-layer cytology in endometrial diagnosis].
    Buccoliero AM; Caldarella A; Noci I; Borri P; Giachi M; Borrani E; Taddei GL
    Pathologica; 2003 Aug; 95(4):179-84. PubMed ID: 14577201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of additional pathology comments indicating suspicion of adenocarcinoma among women diagnosed preoperatively with complex atypical endometrial hyperplasia.
    Suh-Burgmann E; Hung YY; Armstrong MA
    Int J Gynecol Pathol; 2012 May; 31(3):222-6. PubMed ID: 22498938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Atypical endometrial hyperplasia. Prognosis and course].
    Jensen HH; Hussain SF; Pedersen PH; Andreasson B
    Ugeskr Laeger; 2000 Jan; 162(5):666-9. PubMed ID: 10707601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of diagnosis of endometrial hyperplasia by curettage].
    Lü W; Xie X; Ye D
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):816-8. PubMed ID: 11798974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endometrial atypical hyperplasia and subsequent diagnosis of endometrial cancer: a retrospective audit and literature review.
    Pennant S; Manek S; Kehoe S
    J Obstet Gynaecol; 2008 Aug; 28(6):632-3. PubMed ID: 19003662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of strategies to evaluate postmenopausal bleeding.
    Feldman S; Berkowitz RS; Tosteson AN
    Obstet Gynecol; 1993 Jun; 81(6):968-75. PubMed ID: 8497365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complex atypical hyperplasia of the endometrium: differences in outcome following conservative management of pre- and postmenopausal women.
    Brownfoot FC; Hickey M; Ang WC; Arora V; McNally O
    Reprod Sci; 2014 Oct; 21(10):1244-8. PubMed ID: 24516039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.
    Morotti M; Menada MV; Moioli M; Sala P; Maffeo I; Abete L; Fulcheri E; Menoni S; Venturini P; Papadia A
    Gynecol Oncol; 2012 Jun; 125(3):536-40. PubMed ID: 22361087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
    Rubatt JM; Slomovitz BM; Burke TW; Broaddus RR
    Gynecol Oncol; 2005 Nov; 99(2):472-6. PubMed ID: 16099019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The value of curettage in diagnosis of endometrial hyperplasia.
    Xie X; Lu WG; Ye DF; Chen HZ; Fu YF
    Gynecol Oncol; 2002 Jan; 84(1):135-9. PubMed ID: 11748989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.